Overview
Study information
Network: | CAVD |
Grant Affiliation: | Weiss: Protection by Neutralizing Antibodies |
Strategy: | Protein & peptide vaccines |
Study Type: | Pre-Clinical Non-NHP |
Species: | Rabbit |
Stage: | Assays Completed |
Study Start Date: | 2009-09-11 |
Study Made Public: | 2011-08-08 |
Title
Further investigation of the mixing of HIV env antigens, and the effect of Toll-like receptor (TLR) stimulating adjuvants.
Description
CAVD 312 is a preclinical rabbit study assessing combined HIV strains for immunizing potential in different adjuvants, in comparison with each strain alone. Modest neutralization was found with Freunds adjuvant in comparison to TLR agonists.
Sign in to see full information about this study and to download study data.
Products
Carbopol 974P TLR4/7 TLR4 CFA IFA TLR gp140 UG37 gp140 BX08 CN54rgp140 protein gp140 BR29Integrated data
No integrated data is available for this study.
Non-integrated data
No non-integrated data is available for this study.